Human monocytes convert leukotriene B4 to two dihydro-leukotriene B4-metabolites.
Human monocytes metabolize LTB4 by an additional pathway different from omega-oxidation. Reverse-phase high performance liquid chromatography showed four metabolites: 20-COOH-LTB4, 20-OH-LTB4 and two metabolites less polar than LTB4 with an UV maximum at 232 nm. Gas-chromatography mass-spectrometry showed nearly identical mass spectra for both metabolites. The main mass fragments of the two metabolites were increased by two mass units compared to LTB4. Our findings suggest that LTB4 had been reduced to a known and a new dihydro-metabolite of LTB4. Both metabolites together amounted to 85% of total metabolites. The remaining 15% were omega-oxidation products. Thus, the major pathway of LTB4 metabolism by human monocytes is reduction to dihydro-LTB4.
Fauler
J
J
Department of Clinical Pharmacology, Medical School Hannover, West-Germany.
Marx
K H
KH
Kaever
V
V
Frölich
J C
JC
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007975:Leukotriene B4 / Q000378:metabolism*; D013058:Mass Spectrometry; D009000:Monocytes / Q000378:metabolism*
D007975:Leukotriene B4